chr7-140924636-A-T

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 1P and 18B. PP2BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001374258.1(BRAF):​c.68T>A​(p.Met23Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,490,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M23V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

BRAF
NM_001374258.1 missense

Scores

3
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.75
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), BRAF. . Gene score misZ 3.7208 (greater than the threshold 3.09). Trascript score misZ 4.9008 (greater than threshold 3.09). GenCC has associacion of gene with LEOPARD syndrome 3, anaplastic astrocytoma, Noonan syndrome with multiple lentigines, cardiofaciocutaneous syndrome 1, Noonan syndrome, cardiofaciocutaneous syndrome, Costello syndrome, Noonan syndrome 7.
BP4
Computational evidence support a benign effect (MetaRNN=0.19695663).
BP6
Variant 7-140924636-A-T is Benign according to our data. Variant chr7-140924636-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 579533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.0000246 (33/1340936) while in subpopulation SAS AF= 0.000421 (33/78352). AF 95% confidence interval is 0.000308. There are 0 homozygotes in gnomad4_exome. There are 29 alleles in male gnomad4_exome subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High AC in GnomAdExome4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BRAFNM_001374258.1 linkuse as main transcriptc.68T>A p.Met23Lys missense_variant 1/20 ENST00000644969.2
BRAFNM_004333.6 linkuse as main transcriptc.68T>A p.Met23Lys missense_variant 1/18 ENST00000646891.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BRAFENST00000644969.2 linkuse as main transcriptc.68T>A p.Met23Lys missense_variant 1/20 NM_001374258.1
BRAFENST00000646891.2 linkuse as main transcriptc.68T>A p.Met23Lys missense_variant 1/18 NM_004333.6 P4

Frequencies

GnomAD3 genomes
AF:
0.00000668
AC:
1
AN:
149594
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000217
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000795
AC:
10
AN:
125838
Hom.:
0
AF XY:
0.000116
AC XY:
8
AN XY:
69030
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000450
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
33
AN:
1340936
Hom.:
0
Cov.:
26
AF XY:
0.0000437
AC XY:
29
AN XY:
663662
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000421
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149708
Hom.:
0
Cov.:
31
AF XY:
0.0000273
AC XY:
2
AN XY:
73162
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000434
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000918
AC:
3
Asia WGS
AF:
0.000289
AC:
1
AN:
3470

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 02, 2018Variant summary: BRAF c.68T>A (p.Met23Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function (Mutation Taster not included due to low p-value). The variant allele was found at a frequency of 8.3e-05 in 121194 control chromosomes, predominantly at a frequency of 0.00045 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 180-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in BRAF causing Noonan Syndrome and Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. To our knowledge, no occurrence of c.68T>A in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
RASopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeDec 06, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Uncertain
0.044
T
BayesDel_noAF
Pathogenic
0.15
CADD
Uncertain
24
DANN
Benign
0.94
DEOGEN2
Benign
0.33
.;.;T;.;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.72
T;T;T;T;T
M_CAP
Pathogenic
0.68
D
MetaRNN
Benign
0.20
T;T;T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.0
.;.;N;.;.
MutationTaster
Benign
0.65
N
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-0.61
.;.;.;N;.
REVEL
Uncertain
0.42
Sift
Uncertain
0.023
.;.;.;D;.
Sift4G
Benign
0.070
.;.;.;T;.
Polyphen
0.018
.;.;B;.;.
Vest4
0.80
MutPred
0.28
Gain of ubiquitination at M23 (P = 0.0016);Gain of ubiquitination at M23 (P = 0.0016);Gain of ubiquitination at M23 (P = 0.0016);Gain of ubiquitination at M23 (P = 0.0016);Gain of ubiquitination at M23 (P = 0.0016);
MVP
0.99
MPC
1.4
ClinPred
0.16
T
GERP RS
3.2
Varity_R
0.81
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746778122; hg19: chr7-140624436; API